We have located links that may give you full text access.
Industry update: the latest developments in therapeutic delivery.
Therapeutic Delivery 2015 July
The present industry update covers the period 1-31 March 2015, with information sourced from mainly company press releases, regulatory and patent agencies. In a transaction that has been valued at over US$70 billion Actavis has announced it completed the acquisition of Allergan. A number of companies including Columbia Labs, Biohaven and Oxis have announced collaborations/licensing deals in the area of drug delivery technologies. March also saw the announcements from a number of companies including Delcath, Novan and Flamel, of positive clinical trial data for products utilizing different therapeutic delivery options.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app